Mitochondrial fusion proteins and human diseases

Neurology Research International

Volumn 2013, Issue , 2013, Pages

  Ranieri, Michela ^a   Brajkovic, Simona ^a   Riboldi, Giulietta ^a   Ronchi, Dario ^a   Rizzo, Federica ^a   Bresolin, Nereo ^a,b   Corti, Stefania ^a   Comi, Giacomo P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HYBRID PROTEIN; MITOCHONDRIAL DNA; MITOFUSIN 1; MITOFUSIN 2; OPTIC ATROPHY PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; AUTOSOMAL DOMINANT OPTIC ATROPHY; CAENORHABDITIS ELEGANS; CHROMOSOME 19; DROSOPHILA MELANOGASTER; EXON; GENE DELETION; GENE MUTATION; HAPLOINSUFFICIENCY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUNTINGTON CHOREA; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL DNA DEPLETION SYNDROME; MITOCHONDRIAL DYNAMICS; MITOCHONDRION; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SACCHAROMYCES CEREVISIAE;

EID: 84879352561     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2013/293893     Document Type: Review

References (112)

1. Youle R. J., van der Bliek A. M., Mitochondrial fission, fusion, and stress. Science 2012 337 6098 1062 1065
2. Yoneda M., Miyatake T., Attardi G., Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles. Molecular and Cellular Biology 1994 14 4 2699 2712 2-s2.0-0028348251 (Pubitemid 24108251)
3. Nakada K., Inoue K., Ono T., Isobe K., Ogura A., Goto Y. I., Nonaka I., Hayashi J. I., Inter-mitochondrial complementation: mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nature Medicine 2001 7 8 934 940 2-s2.0-0034881326 10.1038/90976 (Pubitemid 32756431)
4. Milone M., Benarroch E. E., Mitochondrial dynamics: general concepts and clinical implications. Neurology 2012 78 20 1612 1619
5. Smirnova E., Griparic L., Shurland D. L., Van der Bliek A. M., Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Molecular Biology of the Cell 2001 12 8 2245 2256 2-s2.0-0035166814 (Pubitemid 33051954)
6. Otera H., Wang C., Cleland M. M., Setoguchi K., Yokota S., Youle R. J., Mihara K., Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. Journal of Cell Biology 2010 191 6 1141 1158 2-s2.0-78650167618 10.1083/jcb.201007152
7. Palmer C. S., Osellame L. D., Laine D., Koutsopoulos O. S., Frazier A. E., Ryan M. T., MiD49 and MiD51, new components of the mitochondrial fission machinery. EMBO Reports 2011 12 6 565 573 2-s2.0-79957988402 10.1038/embor.2011.54
8. De Brito O. M., Scorrano L., Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 2008 456 7222 605 610 2-s2.0-57349100367 10.1038/nature07534
9. Darshi M., Mendiola V. L., Mackey M. R., Murphy A. N., Koller A., Perkins G. A., Ellisman M. H., Taylor S. S., ChChd3, an inner mitochondrial membrane protein, is essential for maintaining Crista integrity and mitochondrial function. Journal of Biological Chemistry 2011 286 4 2918 2932 2-s2.0-78951493639 10.1074/jbc.M110.171975
10. Cipolat S., Martins D. B., Dal Zilio B., Scorrano L., OPA1 requires mitofusin 1 to promote mitochondrial fusion.,Proceedings of the National Academy of Sciences of the United States of America 2004 101 15927 15932 (Pubitemid 39507904)
11. Griparic L., Van Der Wel N. N., Orozco I. J., Peters P. J., Van Der Bliek A. M., Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. Journal of Biological Chemistry 2004 279 18 18792 18798 2-s2.0-2442421118 10.1074/jbc.M400920200 (Pubitemid 38623305)
12. Ishihara N., Fujita Y., Oka T., Mihara K., Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO Journal 2006 25 13 2966 2977 2-s2.0-33746299692 10.1038/sj.emboj.7601184 (Pubitemid 44106750)
13. Olichon A., Baricault L., Gas N., Guillou E., Valette A., Belenguer P., Lenaers G., Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. Journal of Biological Chemistry 2003 278 10 7743 7746 2-s2.0-0037424239 10.1074/jbc.C200677200 (Pubitemid 36800505)
14. Song Z., Ghochani M., McCaffery J. M., Frey T. G., Chan D. C., Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Molecular Biology of the Cell 2009 20 15 3525 3532 2-s2.0-68149103297 10.1091/mbc.E09-03- 0252
15. Palmer C. S., Osellame L. D., Stojanovski D., Ryan M. T., The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cellular Signalling 2011 23 10 1534 1545 2-s2.0-79960729178 10.1016/j.cellsig. 2011.05.021
16. Amati-Bonneau P., Valentino M. L., Reynier P., Gallardo M. E., Bornstein B., Boissière A., Campos Y., Rivera H., De La Aleja J. G., Carroccia R., Iommarini L., Labauge P., Figarella-Branger D., Marcorelles P., Furby A., Beauvais K., Letournel F., Liguori R., La Morgia C., Montagna P., Liguori M., Zanna C., Rugolo M., Cossarizza A., Wissinger B., Verny C., Schwarzenbacher R., Martín M. Á., Arenas J., Ayuso C., Garesse R., Lenaers G., Bonneau D., Carelli V., OPA1 mutations induce mitochondrial DNA instability and optic atrophy "plus" phenotypes. Brain 2008 131 2 338 351 2-s2.0-38849192448 10.1093/brain/awm298 (Pubitemid 351197609)
17. Hudson G., Amati-Bonneau P., Blakely E. L., Stewart J. D., He L., Schaefer A. M., Griffiths P. G., Ahlqvist K., Suomalainen A., Reynier P., McFarland R., Turnbull D. M., Chinnery P. F., Taylor R. W., Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008 131 2 329 337 2-s2.0-38849151612 10.1093/brain/awm272 (Pubitemid 351197604)
18. Rouzier C., Bannwarth S., Chaussenot A., The MFN2 gene is responsible for mitochondrial DNA instability and optic atrophy "plus" phenotype. Brain 2012 135 1 23 34
19. Chen H., Vermulst M., Wang Y. E., Chomyn A., Prolla T. A., McCaffery J. M., Chan D. C., Mitochondrial fusion is required for mtdna stability in skeletal muscle and tolerance of mtDNA mutations. Cell 2010 141 2 280 289 2-s2.0-77951737783 10.1016/j.cell.2010.02.026
20. Hori A., Yoshida M., Ling F., Mitochondrial fusion increases the mitochondrial DNA copy number in budding yeast. Genes to Cells 2011 16 5 527 544 2-s2.0-79955100228 10.1111/j.1365-2443.2011.01504.x
21. Bach D., Pich S., Soriano F. X., Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. Journal of Biological Chemistry 2003 278 17190 17197 (Pubitemid 36799599)
22. Chen K. H., Guo X., Ma D., Dysregulation of HSG triggers vascular proliferative disorders. Nature Cell Biology 2006 6 872 883 (Pubitemid 39207252)
23. Zorzano A., Liesa M., Sebastián D., Mitochondrial fusion proteins: dual regulators of morphology and metabolism. Seminars in Cell & Developmental Biology 2010 21 6 566 574
24. Papanicolaou K. N., Khairallah R. J., Ngoh G. A., Chikando A., Luptak I., O'Shea K. M., Riley D. D., Lugus J. J., Colucci W. S., Lederer W. J., Stanley W. C., Walsh K., Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes. Molecular and Cellular Biology 2011 31 6 1309 1328 2-s2.0-79952265711 10.1128/MCB.00911-10
25. Chen Y., Liu Y., Dorn II G. W., Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circulation Research 2011 109 1327 1331
26. Chen L., Liu T., Tran A., OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. Journal of the American Heart Association 2012 1 5 e003012
27. Reynier P., Amati-Bonneau P., Verny C., Olichon A., Simard G., Guichet A., Bonnemains C., Malecaze F., Malinge M. C., Pelletier J. B., Calvas P., Dollfus H., Belenguer P., Malthièry Y., Lenaers G., Bonneau D., OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. Journal of Medical Genetics 2004 41 9 e110 2-s2.0-17644401441
28. Anikster Y., Kleta R., Shaag A., Gahl W. A., Elpeleg O., Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. American Journal of Human Genetics 2001 69 6 1218 1224 2-s2.0-0035205389 10.1086/324651 (Pubitemid 33124203)
29. Huizing M., Dorward H., Ly L., Klootwijk E., Kleta R., Skovby F., Pei W., Feldman B., Gahl W. A., Anikster Y., OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria. Molecular Genetics and Metabolism 2010 100 2 149 154 2-s2.0-77952097114 10.1016/j.ymgme.2010.03.005
30. Thomas D. Y., Wilkie D., Recombination of mitochondrial drug-resistance factors in Saccharomyces, cerevisiae. Biochemical and Biophysical Research Communications 1968 30 4 368 372 2-s2.0-0014430624
31. Nunnari J., Marshall W. F., Straight A., Murray A., Sedat J. W., Walter P., Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA. Molecular Biology of the Cell 1997 8 7 1233 1242 2-s2.0-0030841103 (Pubitemid 27310471)
32. Bereiter-Hahn J., Voth M., Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microscopy Research and Technique 1994 27 3 198 219 2-s2.0-0028047262 (Pubitemid 24062014)
33. Cortese J. D., Voglino L. A., Hackenbrock C. R., Novel fluorescence membrane fusion assays reveal GTP-dependent fusogenic properties of outer mitochondrial membrane-derived proteins. Biochimica et Biophysica Acta 1998 1371 2 185 198 2-s2.0-0032574956 10.1016/S0005-2736(97)00266-6 (Pubitemid 28269260)
34. Hales K. G., Fuller M. T., Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. Cell 1997 90 1 121 129 2-s2.0-0031440879 10.1016/S0092-8674(00)80319-0 (Pubitemid 28009424)
35. Yaffe M. P., The machinery of mitochondrial inheritance and behavior. Science 1999 283 1493 1497
36. Bleazard W., McCaffery J. M., King E. J., Bale S., Mozdy A., Tieu Q., Nunnari J., Shaw J. M., The dynamin-related GTPase Dnm1 regulates mitochondrial fission in yeast. Nature Cell Biology 1999 1 5 298 304 2-s2.0-0033194038 (Pubitemid 129495781)
37. Labrousse A. M., Zappaterra M. D., Rube D. A., Van der Bliek A. M., C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane. Molecular Cell 1999 4 5 815 826 2-s2.0-0033231549
38. Shin H. W., Shinotsuka C., Torii S., Murakami K., Nakayama K., Identification and subcellular localization of a novel mammalian dynamin-related protein homologous to yeast Vps1p and Dnm1p. Journal of Biochemistry 1997 122 3 525 530 2-s2.0-0030817913 (Pubitemid 27443227)
39. Imoto M., Tachibana I., Urrutia R., Identification and functional characterization of a novel human protein highly related to the yeast dynamin-like GTPase Vps1p. Journal of Cell Science 1998 111 10 1341 1349 2-s2.0-0031799717 (Pubitemid 28274386)
40. Meeusen S., McCaffery J. M., Nunnari J., Mitochondrial fusion intermediates revealed in vitro. Science 2004 305 5691 1747 1752 2-s2.0-4544378532 10.1126/science.1100612 (Pubitemid 39249636)
41. Meeusen S. L., Nunnari J., Mitochondrial fusion in vitro. Methods in Molecular Biology 2007 372 461 466
42. Züchner S., Mersiyanova I. V., Muglia M., Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nature Genetics 2004 36 5 449 451 (Pubitemid 38620027)
43. Zhu D., Kennerson M. L., Walizada G., Züchner S., Vance J. M., Nicholson G. A., Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations. Neurology 2005 65 3 496 497 2-s2.0-23244443545 10.1212/01.wnl.0000171345.62270.29 (Pubitemid 41099829)
44. Züchner S., De Jonghe P., Jordanova A., Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Annals of Neurology 2006 59 2 276 281 (Pubitemid 43202480)
45. Verny C., Loiseau D., Scherer C., Lejeune P., Chevrollier A., Gueguen N., Guillet V., Dubas F., Reynier P., Amati-Bonneau P., Bonneau D., Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology 2008 70 13, part 2 1152 1153 2-s2.0-41549121478 10.1212/01.wnl. 0000289194.89359.a1 (Pubitemid 351464750)
46. Yu-Wai-Man P., Griffiths P. G., Gorman G. S., Multi-system neurological disease is common in patients with OPA1 mutations. Brain 2010 133, part 3 771 786
47. Vielhaber S., Debska-Vielhaber G., Peeva V., Mitofusin 2 mutations affect mitochondrial function by mitochondrial DNA depletion. Acta Neuropathologica 2013 125 2 245 256
48. Lee S., Sterky F. H., Mourier A., Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons. Human Molecular Genetics 2012 21 22 4827 4835
49. Ishihara N., Otera H., Oka T., Mihara K., Regulation and physiologic functions of GTPases in mitochondrial fusion and fission in mammals. Antioxidants & Redox Signaling. In press
50. Anton F., Fres J. M., Schauss A., Pinson B., Praefcke G. J. K., Langer T., Escobar-Henriques M., Ugo1 and Mdm30 act sequentially during Fzo1-mediated mitochondrial outer membrane fusion. Journal of Cell Science 2011 124 7 1126 1135 2-s2.0-79953132685 10.1242/jcs.073080
51. Cohen M. M., Amiott E. A., Day A. R., Leboucher G. P., Pryce E. N., Glickman M. H., McCaffery J. M., Shaw J. M., Weissman A. M., Sequential requirements for the GTPase domain of the mitofusin Fzo1 and the ubiquitin ligase SCFMdm30 in mitochondrial outer membrane fusion. Journal of Cell Science 2011 124 9 1403 1410 2-s2.0-79955535769 10.1242/jcs.079293
52. Tanaka A., Cleland M. M., Xu S., Narendra D. P., Suen D. F., Karbowski M., Youle R. J., Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. Journal of Cell Biology 2010 191 7 1367 1380 2-s2.0-78650729600 10.1083/jcb.201007013
53. Koshiba T., Detmer S. A., Kaiser J. T., Chen H., McCaffery J. M., Chan D. C., Structural basis of mitochondrial tethering by mitofusin complexes. Science 2004 305 5685 858 862 2-s2.0-3843075121 10.1126/science.1099793 (Pubitemid 39038419)
54. Huang P., Galloway C. A., Yoon Y., Control of mitochondrial morphology through differential interactions of mitochondrial fusion and fission proteins. PLoS ONE 2011 6 5 2-s2.0-79957617223 10.1371/journal.pone.0020655 e20655
55. Duvezin-Caubet S., Koppen M., Wagener J., Zick M., Israel L., Bernacchia A., Jagasia R., Rugarli E. I., Imhof A., Neupert W., Langer T., Reichert A. S., OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria. Molecular Biology of the Cell 2007 18 9 3582 3590 2-s2.0-34548349869 10.1091/mbc.E07-02-0164 (Pubitemid 47378695)
56. Pellegrini L., Passer B. J., Canelles M., Lefterov I., Kelly Ganjei J., Fowlkes B. J., Koonin E. V., D'Adamio L., PAMP and PARL, two novel putative metalloproteases interacting with the COOH-terminus of Presenilin-1 and -2. Journal of Alzheimer's Disease 2001 3 2 181 190 2-s2.0-0034979828 (Pubitemid 32566518)
57. Song Z., Chen H., Fiket M., Alexander C., Chan D. C., OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. Journal of Cell Biology 2007 178 5 749 755 2-s2.0-34548313688 10.1083/jcb.200704110 (Pubitemid 47347360)
58. Kar R., Mishra N., Singha P. K., Venkatachalam M. A., Saikumar P., Mitochondrial remodeling following fission inhibition by 15d-PGJ2 involves molecular changes in mitochondrial fusion protein OPA1. Biochemical and Biophysical Research Communications 2010 399 4 548 554 2-s2.0-77956267202 10.1016/j.bbrc.2010.07.108
59. Makino A., Suarez J., Gawlowski T., Han W., Wang H., Scott B. T., Dillmann W. H., Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes. American Journal of Physiology 2011 300 6 1296 1302 2-s2.0-79958797425 10.1152/ajpregu.00437.2010
60. Ishihara N., Jofuku A., Eura Y., Mihara K., Regulation of mitochondrial morphology by membrane potential, and DRP1-dependent division and FZO1-dependent fusion reaction in mammalian cells. Biochemical and Biophysical Research Communications 2003 301 4 891 898 2-s2.0-0037459089 10.1016/S0006-291X(03)00050- 0 (Pubitemid 36279197)
61. Legros F., Lombès A., Frachon P., Rojo M., Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Molecular Biology of the Cell 2002 13 12 4343 4354 2-s2.0-0036906665 10.1091/mbc.E02-06-0330 (Pubitemid 35471190)
62. Ryu S. W., Jeong H. J., Choi M., Karbowski M., Choi C., Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation. Cellular and Molecular Life Sciences 2010 67 16 2839 2850 2-s2.0-77955709957 10.1007/s00018-010-0365-z
63. Vance J. M., The many faces of Charcot-Marie-Tooth disease. Archives of Neurology 2000 57 5 638 640 2-s2.0-0034033449 (Pubitemid 30252795)
64. Harding A. E., Thomas P. K., The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980 103 2 259 280 2-s2.0-0018942439 (Pubitemid 10046623)
65. Polke J. M., Laurá M., Pareyson D., Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations. Neurology 2011 77 2 168 173
66. Kijima K., Numakura C., Izumino H., Umetsu K., Nezu A., Shiiki T., Ogawa M., Ishizaki Y., Kitamura T., Shozawa Y., Hayasaka K., Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A. Human Genetics 2005 116 1-2 23 27 2-s2.0-19944425973 10.1007/s00439-004-1199-2 (Pubitemid 40057912)
67. Chung K. W., Kim S. B., Park K. D., Choi K. G., Lee J. H., Eun H. W., Suh J. S., Hwang J. H., Kim W. K., Seo B. C., Kim S. H., Son I. H., Kim S. M., Sunwoo I. N., Choi B. O., Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 2006 129 8 2103 2118 2-s2.0-33747872317 10.1093/brain/awl174 (Pubitemid 44289075)
68. Verhoeven K., Claeys K. G., Züchner S., MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006 129 8 2093 2102 (Pubitemid 44289074)
69. Calvo J., Funalot B., Ouvrier R. A., Lazaro L., Toutain A., De Mas P., Bouche P., Gilbert-Dussardier B., Arne-Bes M. C., Carrière J. P., Journel H., Minot-Myhie M. C., Guillou C., Ghorab K., Magy L., Sturtz F., Vallat J. M., Magdelaine C., Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations. Archives of Neurology 2009 66 12 1511 1516 2-s2.0-73549111096 10.1001/archneurol.2009.284
70. Amiott E. A., Lott P., Soto J., Kang P. B., McCaffery J. M., DiMauro S., Abel E. D., Flanigan K. M., Lawson V. H., Shaw J. M., Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations. Experimental Neurology 2008 211 1 115 127 2-s2.0-42749094176 10.1016/j.expneurol.2008.01.010
71. Detmer S. A., Chan D. C., Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations. Journal of Cell Biology 2007 176 4 405 414 2-s2.0-33846952150 10.1083/jcb.200611080
72. Dyck P. J., Chance P., Lebo R., Carney J. A., Dyck P. J., Thomas P. K., Hereditary motor and sensory neuropathy. Peripheral Neuropathy 1993 2 3rd Philadelphia, Pa, USA WB Sauders 1094 1136
73. Chalmers R. M., Bird A. C., Harding A. E., Autosomal dominant optic atrophy with asymptomatic peripheral neuropathy. Journal of Neurology Neurosurgery and Psychiatry 1996 60 2 195 196 2-s2.0-0030026084 (Pubitemid 26044195)
74. Huoponen K., Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics 2001 3 3 119 125 2-s2.0-0035404936 10.1007/s100480100115 (Pubitemid 33739050)
75. Alexander C., Votruba M., Pesch U. E. A., Thiselton D. L., Mayer S., Moore A., Rodriguez M., Kellner U., Leo-Kottler B., Auburger G., Bhattacharya S. S., Wissinger B., OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nature Genetics 2000 26 2 211 215 2-s2.0-0033772264 10.1038/79944
76. Voo I., Allf B. E., Udar N., Silva-Garcia R., Vance J., Small K. W., Hereditary motor and sensory neuropathy type VI with optic atrophy. American Journal of Ophthalmology 2003 136 4 670 677 2-s2.0-0141793758 10.1016/S0002-9394(03)00390-8 (Pubitemid 37153182)
77. Kjer P., Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmologica 1959 164 supplement 54 1 147
78. Ferré M., Amati-Bonneau P., Tourmen Y., Malthièry Y., Reynier P., eOPA1: an online database for OPA1 mutations. Human Mutation 2005 25 5 423 428 2-s2.0-27744441594
79. Garcin R., Raverdy P., Delthil S., On a heredo-familial disease combining cataract, optic atrophy, extrapyramidal symptoms and certain defects of Friedreich's disease. (Its nosological position in relation to the Behr's syndrome, the Marinesco-Sjogren syndrome and Friedreich's disease with ocular symptoms. Revue Neurologique 1961 104 373 379
80. Nystuen A., Costeff H., Elpeleg O. N., Apter N., Bonné-Tamir B., Mohrenweiser H., Haider N., Stone E. M., Sheffield V. C., Iraqi-Jewish kindreds with optic atrophy plus (3-methylglutaconic aciduria type 3) demonstrate linkage disequilibrium with the CTG repeat in the 3' untranslated region of the myotonic dystrophy protein kinase gene. Human Molecular Genetics 1997 6 4 563 569 2-s2.0-0030969280 10.1093/hmg/6.4.563 (Pubitemid 27142105)
81. Kleta R., Skovby F., Christensen E., Rosenberg T., Gahl W. A., Anikster Y., 3-Methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings. Molecular Genetics and Metabolism 2002 76 3 201 206 2-s2.0-0036375019 10.1016/S1096-7192(02)00047-1 (Pubitemid 35034552)
82. Hudson G., Chinnery P. F., Mitochondrial DNA polymerase- γ and human disease. Human Molecular Genetics 2006 15 2 R244 R252 2-s2.0-33749001168 10.1093/hmg/ddl233 (Pubitemid 44446800)
83. Kornblum C., Nicholls T. J., Haack T. B., Loss-of-function mutations in MGME1 impair mtDNA replication and cause multisystemic mitochondrial disease. Nature Genetics 2013 45 2 214 219
84. Ronchi D., Di Fonzo A., Lin W., Mutations in DNA2 link progressive myopathy to mitochondrial DNA instability. American Journal of Human Genetics 2013 92 2 293 300
85. Ronchi D., Garone C., Bordoni A., Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions. Brain 2012 135 3404 3415
86. Tyynismaa H., Sun R., Ahola-Erkkilä S., Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Human Molecular Genetics 2012 21 1 66 75
87. Tyynismaa H., Ylikallio E., Patel M., Molnar M. J., Haller R. G., Suomalainen A., A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. American Journal of Human Genetics 2009 85 2 290 295 2-s2.0-68249118218 10.1016/j.ajhg.2009.07.009
88. Amati-Bonneau P., Milea D., Bonneau D., OPA1-associated disorders: phenotypes and pathophysiology. International Journal of Biochemistry & Cell Biology 2009 41 10 1855 1865
89. Lodi R., Tonon C., Valentino M. L., Manners D., Testa C., Malucelli E., La Morgia C., Barboni P., Carbonelli M., Schimpf S., Wissinger B., Zeviani M., Baruzzi A., Liguori R., Barbiroli B., Carelli V., Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations. Archives of Neurology 2011 68 1 67 73 2-s2.0-78651304811 10.1001/archneurol.2010.228
90. Yu-Wai-Man P., Trenell M. I., Hollingsworth K. G., Griffiths P. G., Chinnery P. F., OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy. Brain 2011 134 4 e164 2-s2.0-79953659917 10.1093/brain/awq288
91. Sitarz K. S., Yu-Wai-Man P., Pyle A., MFN2 mutations cause compensatory mitochondrial DNA proliferation. Brain 2012 135 part 8, article e219 1 3
92. Ricci E., Moraes C. T., Servidei S., Tonali P., Bonilla E., DiMauro S., Disorders associated with depletion of mitochondrial DNA. Brain Pathology 1992 2 2 141 147 2-s2.0-0026840484
93. Santos D., Cardoso S. M., Mitochondrial dynamics and neuronal fate in Parkinson's disease. Mitochondrion 2012 12 4 428 437
94. Cho D. H., Nakamura T., Lipton S. A., Mitochondrial dynamics in cell death and neurodegeneration. Cellular and Molecular Life Sciences 2010 67 20 3435 3447 2-s2.0-77957358299 10.1007/s00018-010-0435-2
95. Kim J., Moody J. P., Edgerly C. K., Bordiuk O. L., Cormier K., Smith K., Flint Beal M., Ferrante R. J., Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease. Human Molecular Genetics 2010 19 20 3919 3935 2-s2.0-77957742105 10.1093/hmg/ddq306 ddq306
96. Reddy P. H., Shirendeb U. P., Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease. Biochimica et Biophysica Acta 2012 1822 2 101 110
97. Larsson N. G., Somatic mitochondrial DNA mutations in mammalian aging. Annual Review of Biochemistry 2010 79 683 706 2-s2.0-77953627194 10.1146/annurev-biochem-060408-093701
98. Wallace D. C., Mitochondrial DNA mutations in disease and aging. Environmental and Molecular Mutagenesis 2010 51 5 440 450
99. Wang X., Su B., Lee H. G., Li X., Perry G., Smith M. A., Zhu X., Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. Journal of Neuroscience 2009 29 28 9090 9103 2-s2.0-67650732998 10.1523/JNEUROSCI.1357-09. 2009
100. Manczak M., Reddy P. H., Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage. Human Molecular Genetics 2012 21 11 2538 2547
101. Manczak M., Calkins M. J., Reddy P. H., Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Human Molecular Genetics 2011 20 13 2495 2509 2-s2.0-79958721260 10.1093/hmg/ddr139 ddr139
102. Youle R. J., Narendra D. P., Mechanisms of mitophagy. Nature Reviews Molecular Cell Biology 2011 12 1 9 14
103. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., Yokochi M., Mizuno Y., Shimizu N., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998 392 6676 605 608 2-s2.0-0032499264 10.1038/33416 (Pubitemid 28207717)
104. Gegg M. E., Cooper J. M., Chau K. Y., Rojo M., Schapira A. H. V., Taanman J. W., Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin- dependent manner upon induction of mitophagy. Human Molecular Genetics 2010 19 24 4861 4870 2-s2.0-78649463381 10.1093/hmg/ddq419
105. Misko A. L., Sasaki Y., Tuck E., Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration. Journal of Neuroscience 2012 32 12 4145 4155
106. Pham A. H., Meng S., Chu Q. N., Chan D. C., Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit. Human Molecular Genetics 2012 21 22 4817 4826
107. Manev H., Favaron M., Guidotti A., Costa E., Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death. Molecular Pharmacology 1989 36 1 106 112 2-s2.0-0024475202 (Pubitemid 19191266)
108. Randall R. D., Thayer S. A., Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. Journal of Neuroscience 1992 12 5 1882 1895 2-s2.0-0026608995
109. Budd S. L., Nicholls D. G., Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells. Journal of Neurochemistry 1996 676 2282 2291 (Pubitemid 26392497)
110. Kushnareva Y. E., Gerencser A. A., Bossy B., Loss of OPA1 disturbs cellular calcium homeostasis and sensitizes for excitotoxicity. Cell Death & Differentiation 2013 20 2 353 365
111. Jahani-Asl A., Pilon-Larose K., Xu W., MacLaurin J. G., Park D. S., McBride H. M., Slack R. S., The mitochondrial inner membrane GTPase, optic atrophy 1 (Opa1), restores mitochondrial morphology and promotes neuronal survival following excitotoxicity. Journal of Biological Chemistry 2011 286 6 4772 4782 2-s2.0-79953019314 10.1074/jbc.M110.167155
112. Nguyen D., Alavi M. V., Kim T K. Y., A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death and Disease 2011 2 e240 10.1038/cddis.2011.117